Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.
about
G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian AmazonGenotypic and phenotypic characterization of G6PD deficiency in Bengali adults with severe and uncomplicated malariaAnkyrin-1 Gene Exhibits Allelic Heterogeneity in Conferring Protection Against Malaria.Prevalence of polymorphisms in glucose-6-phosphate dehydrogenase, sickle haemoglobin and nitric oxide synthase genes and their relationship with incidence of uncomplicated malaria in Iganga, Uganda.The role of the red blood cell in host defence against falciparum malaria: an expanding repertoire of evolutionary alterations.Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.Evaluating the Causal Link Between Malaria Infection and Endemic Burkitt Lymphoma in Northern Uganda: A Mendelian Randomization Study.Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.Mutations in the tetramer interface of human glucose-6-phosphate dehydrogenase reveals kinetic differences between oligomeric states.Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia.Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.Medical genetics and genomic medicine in Nigeria.Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approachesHuman candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association studyAssociations between erythrocyte polymorphisms and risks of uncomplicated and severe malaria in Ugandan children: A case control study
P2860
Q33801271-71FD700A-619F-4BE5-B702-4CC8F9130CFDQ37728609-D7632744-A656-44C3-9EC9-F0FCCC3053EDQ38650691-596FED2C-4F16-470B-AF5F-1ADCFC24A3A9Q38849331-95A2F8DF-FF5A-445F-A7D0-9526798DA172Q39026326-34614D8F-42A7-4A8B-A62C-5D78B684AC42Q43923789-6D254262-5D4D-4ABC-A0D9-CD8D449BF452Q46849374-7B1A6375-608E-45A3-92F1-5D15CB2891BCQ48022784-ECD6E889-6954-4C10-8CE6-56D28325FD4AQ51074896-5158D25F-3F05-4598-A5F6-36C340517140Q52310706-9F66C0BE-D791-4EA1-92AB-6E6AD0FE7495Q52348869-6C3BFB84-B6EA-4F6A-A7EB-342058869E37Q55437215-CB523567-6EFD-43DB-AC65-C606C45F2DA3Q56348671-1F67FBCA-A071-401C-B821-F10C4987AB00Q56352373-EFD8E842-DB35-436B-B095-0C50BE3E7702Q56909428-1ACE432E-8B06-4103-8911-9B7D96C0D6DD
P2860
Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterisation of the opposi ...... a and severe malarial anaemia.
@en
Characterisation of the opposi ...... a and severe malarial anaemia.
@nl
type
label
Characterisation of the opposi ...... a and severe malarial anaemia.
@en
Characterisation of the opposi ...... a and severe malarial anaemia.
@nl
prefLabel
Characterisation of the opposi ...... a and severe malarial anaemia.
@en
Characterisation of the opposi ...... a and severe malarial anaemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
Characterisation of the opposi ...... a and severe malarial anaemia.
@en
P2093
Alexander Macharia
Alphaxard Manjurano
Angela Allen
Angeliki Kerasidou
Anita Ghansah
Anna E Jeffreys
Anthony Enimil
Belco Poudiougou
Cao Quang Thai
P2860
P356
10.7554/ELIFE.15085
P407
P50
P577
2017-01-09T00:00:00Z